In This Bull Market, Hard Technology is the Greatest Certainty: Focusing on Robotics, Artificial Intelligence, and Innovative Pharmaceuticals

In This Bull Market, Hard Technology is the Greatest Certainty: Focusing on Robotics, Artificial Intelligence, and Innovative Pharmaceuticals

At a recent important press conference, the chairman of the China Securities Regulatory Commission, Wu Qing, revealed a key signal: the market capitalization of the technology sector in A-shares has surpassed 25%, exceeding the combined total of finance and real estate!This signal is unmistakable: robotics, artificial intelligence, and innovative pharmaceuticals are taking over the baton … Read more

Robotics Industry Leaders Are Here

Robotics Industry Leaders Are Here

This week, the ChiNext Index led the two markets, with growth styles initially prevailing. Communications equipment and innovative pharmaceuticals surged, with industry leaders like New Yisheng and Shenghong Technology reporting significant mid-year earnings increases, pushing their market values above one trillion and continuously reaching new highs, contributing significantly to the ChiNext Index’s gains. Institutional funds … Read more

Market Update: PCB and Innovative Pharmaceuticals Surge

Market Update: PCB and Innovative Pharmaceuticals Surge

On Thursday, the market experienced a day of fluctuating rebounds, with the Shanghai Composite Index reaching a new high of 3463.62 during the session. The index closed up 0.18%, the Shenzhen Component rose 1.17%, and the ChiNext Index increased by 1.9%, leading the three major indices. The total trading volume of the two markets was … Read more

Comparing Two New Productive Forces: AI Robots and Innovative Pharmaceuticals

Comparing Two New Productive Forces: AI Robots and Innovative Pharmaceuticals

AI and robots are still in the “hype expectation” phase of strategic investment, with a chaotic commercialization path and application scenarios lagging behind technological hype. The demand for shovels (AI computing power and chips) has surged, but AI companies and humanoid robots have yet to see signs of profitability. There are breakthroughs in the B2B … Read more